311 related articles for article (PubMed ID: 30409035)
1. Hypoplastic thrombocytopenia and platelet transfusion: therapeutic goals.
Karakatsanis SJ; Papadatos SS; Syrigos KN
Hosp Pract (1995); 2019 Feb; 47(1):16-23. PubMed ID: 30409035
[TBL] [Abstract][Full Text] [Related]
2. New strategies for the optimal use of platelet transfusions.
Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
[TBL] [Abstract][Full Text] [Related]
3. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
Stanworth SJ; Hyde C; Brunskill S; Murphy MF
Br J Haematol; 2005 Dec; 131(5):588-95. PubMed ID: 16351634
[TBL] [Abstract][Full Text] [Related]
4. Thrombocytopenia and platelet transfusions in patients with cancer.
Valent J; Schiffer CA
Cancer Treat Res; 2011; 157():251-65. PubMed ID: 21052961
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
[TBL] [Abstract][Full Text] [Related]
6. Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions.
Stanworth SJ; Dyer C; Choo L; Bakrania L; Copplestone A; Llewelyn C; Norfolk D; Powter G; Littlewood T; Wood EM; Murphy MF;
Transfus Med Rev; 2010 Jul; 24(3):163-71. PubMed ID: 20656185
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
[TBL] [Abstract][Full Text] [Related]
8. A no-prophylaxis platelet-transfusion strategy for hematologic cancers.
Stanworth SJ; Estcourt LJ; Powter G; Kahan BC; Dyer C; Choo L; Bakrania L; Llewelyn C; Littlewood T; Soutar R; Norfolk D; Copplestone A; Smith N; Kerr P; Jones G; Raj K; Westerman DA; Szer J; Jackson N; Bardy PG; Plews D; Lyons S; Bielby L; Wood EM; Murphy MF;
N Engl J Med; 2013 May; 368(19):1771-80. PubMed ID: 23656642
[TBL] [Abstract][Full Text] [Related]
9. Eliminate prophylactic platelet transfusions?
Slichter SJ
N Engl J Med; 2013 May; 368(19):1837-8. PubMed ID: 23656650
[No Abstract] [Full Text] [Related]
10. POLYMORPHISM OF COLLECTION, TRANSFUSION AND EFFECTIVENESS OF DONOR PLATELETS CONCENTRATES.
Gubanova MN; Ayupova RF; Zhiburt EB
Anesteziol Reanimatol; 2017 Jan; 62(1):77-79. PubMed ID: 29932588
[TBL] [Abstract][Full Text] [Related]
11. Platelet transfusions for patients with haematological malignancies: who needs them?
Estcourt LJ; Stanworth SJ; Murphy MF
Br J Haematol; 2011 Aug; 154(4):425-40. PubMed ID: 21615375
[TBL] [Abstract][Full Text] [Related]
12. Dose of prophylactic platelet transfusions and prevention of hemorrhage.
Slichter SJ; Kaufman RM; Assmann SF; McCullough J; Triulzi DJ; Strauss RG; Gernsheimer TB; Ness PM; Brecher ME; Josephson CD; Konkle BA; Woodson RD; Ortel TL; Hillyer CD; Skerrett DL; McCrae KR; Sloan SR; Uhl L; George JN; Aquino VM; Manno CS; McFarland JG; Hess JR; Leissinger C; Granger S
N Engl J Med; 2010 Feb; 362(7):600-13. PubMed ID: 20164484
[TBL] [Abstract][Full Text] [Related]
13. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ
Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838
[TBL] [Abstract][Full Text] [Related]
14. Different Platelet Count Thresholds to Guide Use of Prophylactic Platelet Transfusions for Patients With Hematological Disorders After Myelosuppressive Chemotherapy or Stem Cell Transplantation.
Estcourt LJ; Stanworth SJ; Murphy MF
JAMA Oncol; 2016 Aug; 2(8):1091-2. PubMed ID: 27415031
[TBL] [Abstract][Full Text] [Related]
15. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
[TBL] [Abstract][Full Text] [Related]
16. Interventions to reduce platelet prophylactic transfusions in patients with hypoproliferative thrombocytopenia: providing patients with the full benefit.
Vamvakas EC; Hitzler WE
Clin Lab; 2013; 59(5-6):459-64. PubMed ID: 23865342
[TBL] [Abstract][Full Text] [Related]
17. Platelet Transfusions in Patients with Hypoproliferative Thrombocytopenia: Conclusions from Clinical Trials and Current Controversies.
Crighton GL; Estcourt LJ; Wood EM; Stanworth SJ
Hematol Oncol Clin North Am; 2016 Jun; 30(3):541-60. PubMed ID: 27112995
[TBL] [Abstract][Full Text] [Related]
18. [The efficacy and safety of autologous cryopreserved platelet transfusion in management of thrombocytopenia after chemotherapy in hematological malignancy].
Liu GQ; Ding HF; Lu XJ; Xu M; Xing J; Zhao X; Han F; Shang YH
Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):188-91. PubMed ID: 22781890
[TBL] [Abstract][Full Text] [Related]
19. Optimizing platelet transfusion therapy.
Heal JM; Blumberg N
Blood Rev; 2004 Sep; 18(3):149-65. PubMed ID: 15183900
[TBL] [Abstract][Full Text] [Related]
20. Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia.
Vinholt PJ; Alnor A; Nybo M; Hvas AM
Platelets; 2016 Sep; 27(6):547-54. PubMed ID: 27025360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]